Science · Earlier selection
US grant backs research into shorter tuberculosis treatment
Weill Cornell Medicine has received a five-year, US$17.4 million research grant to investigate ways of shortening tuberculosis treatment.
The 17 September announcement describes four linked projects examining how bacteria survive and respond to combinations of drugs. The award comes from the US National Institute of Allergy and Infectious Diseases. It funds research; it does not mean a shorter treatment has already been proven.
GO TO THE SOURCE
Cornell University ↗ (opens a new tab)Primary institutional report or research paper, independently condensed. Findings and proposals are attributed to the source, with their limitations; no source prose, charts or photography reproduced.
AI-assisted original summary, checked against the linked source on 20 Sept 2026, 01:29 BST. Illustration is AI generated and does not document the event.
Report an error or rights concern